Patients stabilised post-ACS ‘remain at risk of sudden death’
Novel findings from the IMPROVE-IT trial are a wake-up call to optimise therapy and the monitoring of vulnerable patients, researchers say
Patients stabilised within 10 days of an acute coronary syndrome remain at long-term risk of sudden death and the risk climbs even higher after additional cardiac events, a major study shows.
US and Canadian researchers say their findings provide novel insights into the phenomenon in stabilised patients and should help clinicians identify opportunities to improve post-acute coronary syndrome (post-ACS) care.
